University Of L'Aquila
- Address
- lock Available on a paid plan
University Of L'Aquila
The University of L'Aquila is a distinguished research institution engaged in diverse clinical investigations spanning neurological and musculoskeletal conditions. The center demonstrates particular expertise in acute cerebrovascular interventions and orthopedic inflammatory disorders, contributing to the advancement of evidence-based therapeutic approaches.
- Acute stroke management and intracerebral hemorrhage treatment protocols
- Hemostatic therapies and early mortality prevention in neurological emergencies
- Musculoskeletal inflammatory conditions including rotator cuff tendinopathy
Research initiatives at the center include critical evaluation of tranexamic acid for hyperacute spontaneous intracerebral hemorrhage, focusing on early mortality outcomes and clinical effectiveness in stroke populations. The institution also investigates novel biological therapies for moderate to severe rotator cuff tendinopathy, examining the therapeutic potential of targeted immunomodulatory agents in improving physical shoulder symptoms and functional outcomes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1University Of Nottingham1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in University Of L'Aquila
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A randomized, parallel-group, 24 week, double-blind, placebo-controlled, multicenter Phase 3 study to assess the efficacy and safety of secukinumab compared to placebo in adult patients with active rotator cuff tendinopathy | Novartis Pharma AG | Phase III | Not Recruiting | Oct 2023 | Dec 2024 |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Other Analgesics And Antipyretics | 1 | Unknown | 2023-10-16 | 2023-10-16 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.